Legal Representation
Attorney
Ray Thomas, Jr.
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 18, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jun 18, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Nov 2, 2011 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Nov 1, 2011 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Oct 31, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 31, 2011 | EXT5 | S | SOU EXTENSION 5 FILED |
| May 21, 2011 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| May 20, 2011 | EX4G | S | SOU EXTENSION 4 GRANTED |
| May 12, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 12, 2011 | EXT4 | S | SOU EXTENSION 4 FILED |
| Nov 13, 2010 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Nov 12, 2010 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 8, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 8, 2010 | EXT3 | S | SOU EXTENSION 3 FILED |
| May 28, 2010 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| May 27, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 22, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| May 4, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 4, 2010 | EXT2 | S | SOU EXTENSION 2 FILED |
| Nov 6, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 6, 2009 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 6, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 19, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Feb 24, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 18, 2009 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 4, 2009 | NPUB | O | NOTICE OF PUBLICATION |
| Jan 21, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 21, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jan 16, 2009 | ALIE | A | ASSIGNED TO LIE |
| Jan 16, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 16, 2009 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
| Jan 13, 2009 | I | PAPER RECEIVED | |
| Dec 30, 2008 | CNRT | F | NON-FINAL ACTION MAILED |
| Dec 29, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 29, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 17, 2008 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; Diagnostic reagents and contrast media for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005